| Nome |
# |
|
Acute kidney injury in cirrhotic patients undergoing contrast-enhanced computed tomography, file de3e52b0-56f3-762d-e053-3705fe0a30e0
|
38
|
|
NS3 Variability in Hepatitis C Virus Genotype 1A Isolates from Liver Tissue and Serum Samples of Treatment-Naïve Patients with Chronic Hepatitis C, file de3e52b1-9027-762d-e053-3705fe0a30e0
|
22
|
|
Over time evaluation of glycaemic control in direct-acting antiviral-treated hepatitis C virus/diabetic individuals with chronic hepatitis or with cirrhosis, file de3e52b4-fa29-762d-e053-3705fe0a30e0
|
20
|
|
Behaviour of occult HBV infection in HCV-infected patients under treatment with direct-acting antivirals, file de3e52b1-c759-762d-e053-3705fe0a30e0
|
19
|
|
Occult hepatitis B virus infection, file de3e52ae-ac84-762d-e053-3705fe0a30e0
|
17
|
|
Impact of Occult Hepatitis B Virus Infection on the Outcome of Chronic Hepatitis C., file de3e52ae-f4d3-762d-e053-3705fe0a30e0
|
12
|
|
Hypergammaglobulinemia is a strong predictor of disease progression, hepatocellular carcinoma, and death in patients with compensated cirrhosis., file de3e52b1-361f-762d-e053-3705fe0a30e0
|
12
|
|
Over time evaluation of glycaemic control in direct-acting antiviral-treated hepatitis C virus/diabetic individuals with chronic hepatitis or with cirrhosis, file 048dce26-c2c1-4911-8f25-b66ef70ef630
|
11
|
|
Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral Agents., file de3e52b1-85aa-762d-e053-3705fe0a30e0
|
11
|
|
Antibody to hepatitis B virus core antigen positivity is a predictor of non-alcoholic fatty liver disease severity, file 91b45130-01f6-47e2-921f-f901e9e2771e
|
8
|
|
Mucocutaneous toxicity during simeprevir treatment for hepatitis C. A single institution, retrospective case series, file de3e52b1-0f35-762d-e053-3705fe0a30e0
|
7
|
|
Evaluation of liver enzyme levels and identification of asymptomatic liver disease patients in primary care, file de3e52b0-db6e-762d-e053-3705fe0a30e0
|
6
|
|
Is early recurrence of hepatocellular carcinoma in HCV cirrhotic patients affected by treatment with direct-acting antivirals? A prospective multicentre study, file de3e52b1-23ea-762d-e053-3705fe0a30e0
|
6
|
|
Direct-acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients, file de3e52b1-fdbc-762d-e053-3705fe0a30e0
|
6
|
|
null, file de3e52b3-275d-762d-e053-3705fe0a30e0
|
6
|
|
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial., file de3e52b1-9029-762d-e053-3705fe0a30e0
|
5
|
|
Is Transient Elastography Needed for Noninvasive Assessment of High-Risk Varices? The REAL Experience, file de3e52b2-c7ff-762d-e053-3705fe0a30e0
|
5
|
|
High Prevalence of Severe Hepatic Fibrosis in Type 2 Diabetic Outpatients Screened for Non-Alcoholic Fatty Liver Disease, file 3d2ffdda-0a08-4f2e-873a-0b7fb9f456c5
|
4
|
|
Genomic heterogeneity of hepatitis B virus (HBV) and outcome of perinatal HBV infection., file de3e52ae-d129-762d-e053-3705fe0a30e0
|
4
|
|
Atrial fibrillation in patients with cirrhosis, file de3e52af-700a-762d-e053-3705fe0a30e0
|
4
|
|
Platelet Count Does Not Predict Bleeding in Cirrhotic Patients: Results from the PRO-LIVER Study, file de3e52b1-356a-762d-e053-3705fe0a30e0
|
4
|
|
Direct-acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients, file de3e52b4-b3bd-762d-e053-3705fe0a30e0
|
4
|
|
A Keynesian perspective on the health economics of kidney transplantation would strengthen the value of the whole organ donation and transplantation service, file a2fc94a2-f582-46de-8e94-82a1b3e8d5a7
|
3
|
|
A Keynesian perspective on the health economics of kidney transplantation would strengthen the value of the whole organ donation and transplantation service, file dae1417f-aa67-4120-b630-5d604ccec853
|
3
|
|
TT virus has a ubiquitous diffusion in human body tissues: analyses of paired serum and tissue samples., file de3e52ae-bdeb-762d-e053-3705fe0a30e0
|
3
|
|
Lack of the NS5B S282T mutation in HCV isolates from liver tissue of naive patients with HCV genotype-1b infection., file de3e52af-988a-762d-e053-3705fe0a30e0
|
3
|
|
Prevalence of hepatitis B and C viral infections in hospitalized patients with increased liver enzyme levels and with no known history of hepatic disease, file de3e52b5-6823-762d-e053-3705fe0a30e0
|
3
|
|
Assessing Genomic Mutations in SARS-CoV-2: Potential Resistance to Antiviral Drugs in Viral Populations from Untreated COVID-19 Patients, file f74d8059-cc78-49da-9047-9720b00c4506
|
3
|
|
Effects of Proton Pump Inhibitors in Cirrhotic Patients: What Do We Really Know?, file 93552c80-aaa3-40c1-8014-3056b1c91386
|
2
|
|
Virological profiles in hepatitis B virus inactive carriers: monthly evaluation in 1-year follow-up study, file de3e52ae-b87c-762d-e053-3705fe0a30e0
|
2
|
|
Fibroscan: a new non-invasive method for evaluation of liver dysfunction in Turner syndrome, file de3e52ae-c396-762d-e053-3705fe0a30e0
|
2
|
|
Hepatitis B virus PreS/S gene variants: Pathobiology and clinical implications., file de3e52ae-f163-762d-e053-3705fe0a30e0
|
2
|
|
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study, file de3e52b1-4563-762d-e053-3705fe0a30e0
|
2
|
|
Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral Agents., file de3e52b4-39c7-762d-e053-3705fe0a30e0
|
2
|
|
Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: an individual patient data meta-analysis, file de3e52b4-fa2b-762d-e053-3705fe0a30e0
|
2
|
|
Cirrhotic Patients with Bacterial Infection and Negative Cultures Have a More Advanced Disease and an Increased Short-Term Mortality Rate, file de3e52b5-27ca-762d-e053-3705fe0a30e0
|
2
|
|
Rate of hepatocellular carcinoma diagnosis in cirrhotic patients with ultrasound‑detected liver nodules, file de3e52b5-3e8b-762d-e053-3705fe0a30e0
|
2
|
|
Health economics aspects of kidney transplantation in Sicily: a benchmark analysis on activity and estimated savings, file 2fff2bdb-65b3-445a-9b85-2266782f299b
|
1
|
|
Hypergammaglobulinemia before Starting DAA Therapy Is A Strong Predictor of Disease Progression in Cirrhotic Patients Even after HCV Clearance, file 3157df58-e2e4-4ef6-a32b-9a1fa0aed24b
|
1
|
|
Trends in chronic hepatitis B virus infection in Italy over a 10-year period: Clues from the nationwide PITER and MASTER cohorts toward
elimination, file 64474820-d777-4fa5-97e8-01078358f0ea
|
1
|
|
New-Onset Atrial Fibrillation and Early Mortality Rate in COVID-19 Patients: Association with IL-6 Serum Levels and Respiratory Distress, file 69965745-5371-438f-8620-fdaac4f6b613
|
1
|
|
Impact of Sex and Gender on Clinical Management of Patients with Advanced Chronic Liver Disease and Type 2 Diabetes, file 88b78df8-cf19-45bd-834c-d69ff22c843d
|
1
|
|
Occult hepatitis B virus infection is associated with the development of hepatocellular carcinoma in chronic hepatitis C patients., file de3e52ae-b7fc-762d-e053-3705fe0a30e0
|
1
|
|
Pre-S2 defective hepatitis B virus infection in patients with fulminant hepatitis., file de3e52ae-bdf2-762d-e053-3705fe0a30e0
|
1
|
|
Hepatitis E virus infection as a cause of acute hepatitis in Southern Italy, file de3e52ae-d125-762d-e053-3705fe0a30e0
|
1
|
|
Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease, file de3e52ae-d126-762d-e053-3705fe0a30e0
|
1
|
|
Long-term response to interferon alpha is unrelated to "interferon sensitivity determining region" variability in patients with chronic hepatitis C virus-1b infection, file de3e52ae-d127-762d-e053-3705fe0a30e0
|
1
|
|
Fever and rhomboid target lesion in decompensated cirrhosis, file de3e52ae-dfeb-762d-e053-3705fe0a30e0
|
1
|
|
The impact of infection by multidrug-resistant agents in patients with cirrhosis. A multicenter prospective study, file de3e52b0-711b-762d-e053-3705fe0a30e0
|
1
|
|
Elective endoscopic variceal ligation is not a risk factor for bacterial infection in patients with liver cirrhosis, file de3e52b1-a5d9-762d-e053-3705fe0a30e0
|
1
|
|
Portal vein thrombosis relevance on liver cirrhosis: Italian Venous Thrombotic Events Registry, file de3e52b3-4d6b-762d-e053-3705fe0a30e0
|
1
|
|
Hypergammaglobulinemia is a strong predictor of disease progression, hepatocellular carcinoma, and death in patients with compensated cirrhosis., file de3e52b3-5893-762d-e053-3705fe0a30e0
|
1
|
|
The HCV Sicily Network: A web-based model for the management of HCV chronic liver diseases, file de3e52b3-ea46-762d-e053-3705fe0a30e0
|
1
|
|
Serum Albumin Is Inversely Associated With Portal Vein Thrombosis in Cirrhosis, file de3e52b3-fdc7-762d-e053-3705fe0a30e0
|
1
|
|
Platelet Count Does Not Predict Bleeding in Cirrhotic Patients: Results from the PRO-LIVER Study, file de3e52b4-29c0-762d-e053-3705fe0a30e0
|
1
|
|
Incidence and Recurrence of Portal Vein Thrombosis in Cirrhotic Patients, file de3e52b4-3727-762d-e053-3705fe0a30e0
|
1
|
| Totale |
286 |